Effects of virtual reality-based cognitive training for adolescents with depressive episodes: A pilot randomized controlled study.
Sihui LyuShuming ZhongYange LuoShuya YanHanglin RanManying DuanKailin SongKaiwei YeHaofei MiaoYilei HuZijin SongShunkai LaiYiliang ZhangJiali HeYunxia ZhuYanbin JiaPublished in: Psychiatry research (2024)
Cognitive impairment is a common symptom in depression, yet few intervention strategies target adolescents. This study investigated the effects of an attention and working memory cognitive training system based on virtual reality (VRCT) in adolescents with mild to moderate depressive episodes. Adolescents with depression were randomized into a VR training group (VRG, n = 47) or a waitlist control group (WT, n = 46). The VR training consisted of three 10-min tasks per session, conducted three sessions per week for 20 sessions over 7 weeks. Forty-four healthy adolescents participated as a comparison group for baseline cognitive assessment. Cognitive functions and depressive symptoms were assessed using the Das-Naglieri cognitive assessment system, driven by the Planning, Attention, Simultaneous, and Successive (PASS) processing theory, and the Hamilton Depression Rating Scale-24 at pre- and post-intervention. Baseline results indicated significantly lower cognitive scores in patients compared to healthy adolescents. Post-intervention, the VRG demonstrated significant improvements in all four cognitive scales (effect sizes 0.56 to 0.76) and a significant reduction in depressive symptoms compared to the WT. These findings suggest that VRCT holds potential for improving cognitive impairments and alleviating depressive symptoms in adolescents with depression. Further large-scale and follow-up studies are necessary to confirm long-term benefits.
Keyphrases
- virtual reality
- depressive symptoms
- young adults
- working memory
- physical activity
- sleep quality
- randomized controlled trial
- social support
- cognitive impairment
- transcranial direct current stimulation
- bipolar disorder
- clinical trial
- newly diagnosed
- risk assessment
- stress induced
- systemic lupus erythematosus
- chronic kidney disease
- double blind
- single molecule
- human health
- gestational age